{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:38:13Z","timestamp":1790401093833,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jaip.2023.12.006","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T02:11:36Z","timestamp":1702260696000},"page":"948-959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study"],"prefix":"10.1016","volume":"12","author":[{"given":"Leonard B.","family":"Bacharier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa W.","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance H.","family":"Katelaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Deschildre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Phipatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Altincatal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda P.","family":"Mannent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle","family":"Akinlade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juby A.","family":"Jacob-Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamo","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Hardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.12.006_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5334\/aogh.2416","article-title":"Pediatric asthma: a global epidemic","volume":"85","author":"Serebrisky","year":"2019","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.jaip.2023.12.006_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.12.006_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaip.2017.04.031","article-title":"Severe asthma in children","volume":"5","author":"Ramratnam","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.12.006_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1067\/mai.2001.111590","article-title":"FEV (1) is associated with risk of asthma attacks in a pediatric population","volume":"107","author":"Fuhlbrigge","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.006_bib5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of growth and decline in lung function in persistent childhood asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/thoraxjnl-2017-210650","article-title":"Exacerbation risk and characterisation of the UK\u2019s asthma population from infants to old age","volume":"73","author":"Bloom","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.12.006_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S2213-2600(20)30399-4","article-title":"Advances in understanding and reducing the burden of severe asthma in children","volume":"8","author":"Pijnenburg","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2019","article-title":"How can we minimise the use of regular oral corticosteroids in asthma?","volume":"29","author":"Bourdin","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2023.12.006_bib11","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.1323896111","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.12.006_bib12","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.1324022111","article-title":"Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.12.006_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.006_bib15","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in children with uncontrolled moderate-to-severe asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardization of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Resir J"},{"key":"10.1016\/j.jaip.2023.12.006_bib20","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.12.006_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.12.006_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ACI.0000000000000348","article-title":"Childhood asthma is a risk factor for the development of chronic obstructive pulmonary disease","volume":"17","author":"McGeachie","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.006_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ACI.0000000000000810","article-title":"Predicting the course of asthma from childhood until early adulthood","volume":"22","author":"Koefoed","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.006_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/thoraxjnl-2019-213068","article-title":"Lung function and asthma control in school-age children managed in UK primary care: a cohort study","volume":"75","author":"Lo","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.12.006_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rmed.2016.01.012","article-title":"Bronchodilator response as a marker of poor asthma control","volume":"112","author":"Heffler","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib26","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.12.006_bib27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2019.10.037","article-title":"IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyper-responsiveness in isolated human small airways","volume":"145","author":"Manson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.006_bib28","first-page":"427","article-title":"The role of biologics in the management of asthma in the pediatric patient","volume":"26","author":"Morris","year":"2021","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.12.006_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(22)01198-9","article-title":"Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"400","author":"Jackson","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.12.006_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2500\/aap.2017.38.4067","article-title":"Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: a systematic literature review","volume":"38","author":"Corren","year":"2017","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.12.006_bib31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s12325-022-02399-5","article-title":"Dupilumab-treated patients with asthma in the real world: the RAPID Global Registry","volume":"40","author":"Gall","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2023.12.006_bib32","article-title":"Comparison between clinical trials and real-world evidence studies on biologics for severe asthma","volume":"50","author":"Menzella","year":"2022","journal-title":"J\u00a0Int Med Res"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823013521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823013521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:59:00Z","timestamp":1729097940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823013521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2213219823013521"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.12.006","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}